Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking, above VivioMD at #124.
Read the Care Bare Rx review →
Provider review
A real 49-state disclosure — but no price without completing a full intake quiz.
Every price VivioMD has sits behind an intake quiz. The only figures its public site will show you are struck-through "FREE" line items and $239 for an oral tablet — nothing for the injectables it actually sells.
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What VivioMD discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Not disclosed
No dollar figure could be found on its own public pages.
No hidden commitment trap
Disclosed
The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking, above VivioMD at #124.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not disclosed
Prices read from VivioMD's own site · August 2026
What they advertise
Pricing not published. VivioMD's homepage promises "Flat pricing — never goes up as your dose increases" and then attaches no dollar figure to it, anywhere.
What you actually pay
Pricing not published. The whole flow sits inside a quiz app at api.viviomd.com/funnel/, and you reach a number only by finishing the quiz. What the site will show without one: struck-through "FREE" line items for bundled visit and shipping fees, and a single $239 figure for an oral semaglutide tablet. Neither injectable has a price you can see before signing up.
VivioMD (viviomd.com, legal entity VivioMD Group LLC) sells compounded tirzepatide and compounded semaglutide. No sermorelin.
VivioMD appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
VivioMD does not name the pharmacy that fills your prescription.
Unknown. Its FAQ names four partner pharmacies outright — RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx — the same four that Fridays and Taurus Meds name, which points to a shared white-label network rather than anything disqualifying. What no page does is tie any of the four to a 503A or 503B category.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
List published. Its FAQ says plainly: "Vivio is available in 49 U.S. states. At this time we're unable to provide services in Louisiana or outside the United States."
The part they would rather you skipped
VivioMD will not tell you what it charges until you have told it about your health. There is no price for compounded tirzepatide or compounded semaglutide anywhere on the public site — not a range, not a starting figure — and the only way to one is a full personal-health intake quiz. The homepage still promises "Flat pricing," which is a claim about a number it won't show you. Separately, an FDA warning letter is on record and open: VivioMD Group LLC dba VivioMD, MARCS-CMS 728295, June 8, 2026, citing a mislabeled-compounder claim — VivioMD's own name pictured on the label of a drug it does not compound. That single citation makes it the narrowest of the five June 8 letters here; it is still a letter.
None of this is unique to VivioMD — the whole category shares it.
The providers we rank on our tirzepatide provider ranking — the most specific board VivioMD sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.





149 more providers rank on our tirzepatide provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check VivioMD's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect VivioMD's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on VivioMD's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
VivioMD
See current pricing